South Korean scientists have developed a method using mussel adhesive protein to connect severed nerve ends without the need to use suture threads.
A joint research team from Pohang University of Science and Technology, Ewha Woman's University, and the Catholic University of Korea Seoul St. Mary’s Hospital announced that it had developed a hydrogel adhesive for medical use based on mussel adhesive protein.
Nerves are one of the more difficult tissues to replicate. As a result, when they are cut, the only option to rejoin them is to carefully sew them together with suture threads.
This approach, however, necessitates a high level of medical expertise and takes a long time. Furthermore, there is a possibility that the secondary injury induced by suture thread penetration will impede nerve cell proliferation.
The researchers aimed to address these issues by transforming mussel adhesive protein into a jelly-like photo-crosslinking hydrogel adhesive.
The protein secreted by mussels to adhere to the moist surfaces of solid rocks is known as mussel adhesive protein.
When not exposed to light, this adhesive lives as a liquid. When exposed to visible light, it rapidly transforms into a hydrogel with sticky properties.
The use of this glue to connect severed nerve segments helps to avoid further injury and minimize immunological inflammation.


Australia’s December Trade Surplus Expands but Falls Short of Expectations
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Thailand Inflation Remains Negative for 10th Straight Month in January
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 



